At-Home Testing Kits Market to Reach US$ 17.25 Billion by 2033 at 7.1% CAGR; North America Leads with 40% Share | Key Players Abbott, Roche, BD

The At-Home Testing Kits market reached US$ 9.53 billion in 2024 and is expected to reach US$ 17.25 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033. Market growth is driven by increasing demand for convenient, private, and rapid diagnostic solutions, along with rising awareness of preventive healthcare and early disease detection. At-home testing kits are widely used for conditions such as infectious diseases, pregnancy, fertility, diabetes, cholesterol, and genetic screening, offering users faster results without the need for clinical visits.

Strong momentum is coming from advancements in diagnostic accuracy, digital integration, and expanded test portfolios, making at-home kits more reliable and user-friendly. Growing adoption of telehealth, improved regulatory acceptance, and rising consumer preference for self-monitoring are further accelerating demand. North America holds the largest market share due to high healthcare spending and strong consumer adoption, while Asia-Pacific is emerging as a high-growth region, supported by increasing health awareness, expanding e-commerce access, and improving diagnostic infrastructure.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/at-home-testing-kits-market?sai-v

The At-Home Testing Kits market refers to the sector of diagnostic products that allow individuals to collect samples and perform health, genetic, or wellness tests conveniently at home.

Key Developments
✅ January 2026: In North America, the at-home testing kits market expanded as major healthcare and diagnostics companies including Abbott Laboratories, Quest Diagnostics, Everlywell, and LetsGetChecked enhanced product portfolios with advanced self-administered tests for infectious diseases, chronic conditions, and wellness markers, supported by smartphone integration and telehealth connectivity.

✅ January 2026: In Europe, increased consumer focus on preventive health and digital health adoption drove uptake of at-home diagnostics, with providers such as BioTech Diagnostics, Babylon Health, weCare Health Services, and Thorne Research (EU distribution) improving ease-of-use, multilingual guidance, and regulatory compliance to expand accessibility.

✅ December 2025: In Asia-Pacific, rapid urbanization and rising health awareness boosted demand for rapid at-home kits for infectious disease screening, glucose monitoring, and fertility tracking, with offerings from SD Biosensor, Alere (Abbott), OmniPath Diagnostics, and AccuSure Health tailored to diverse markets and price points.

✅ December 2025: Globally, integration of digital support tools, app-based guidance, and AI-assisted interpretation improved user experience and accuracy for at-home tests, with platforms enabling result tracking, tele-consultation support, and condition monitoring across wellness and disease management categories.

✅ November 2025: In Latin America, healthcare access challenges and increasing consumer interest in self-care encouraged adoption of affordable at-home testing kits from Diagnostica Stago, Bioclin, Wiener Lab, and regional distributors to support glucose, cholesterol, and infectious disease screening outside clinical settings.

✅ October 2025: Worldwide, growth in specialty at-home test categories-such as hormone panels, microbiome analysis, and genetic risk screening-expanded the market as innovators and research labs collaborated to enhance kit accuracy, expand biomarker coverage, and support personalized health insights.

Mergers & Acquisitions
✅ January 2026: Abbott Laboratories acquired HomeTest AI, a developer of scalable at-home diagnostics platforms with integrated app-based interpretation and telehealth linkage, to strengthen its consumer diagnostic portfolio and improve digital support capabilities.

✅ December 2025: Everlywell, Inc. acquired NutriCheck Health, a provider of nutritional biomarker and wellness at-home test kits, to broaden its range of health screening offerings and improve personalized health insights for consumers.

✅ November 2025: LetsGetChecked acquired ChronicMonitor Tech, a specialist in remote chronic condition test kits and telemonitoring integration, to expand its home-based chronic disease management solutions.

Key Players
Abbott | F. Hoffmann-La Roche Ltd | BD | Siemens Healthcare Private Limited | Geratherm Medical AG | OraQuick | SEKISUI Diagnostics | BioLytical Laboratories Inc. (INSTI) | PRIMA Lab SA | Nova Biomedical | Everlywell | Cardinal Health | Bionime Corporation | Others

Key Highlights
Abbott holds 26% market share, driven by its strong portfolio of rapid diagnostic tests, point-of-care solutions, global manufacturing scale, and extensive distribution network across developed and emerging markets.

F. Hoffmann-La Roche Ltd accounts for 20% market share, supported by its leadership in in-vitro diagnostics, advanced assay technologies, and strong integration of diagnostics with personalized healthcare solutions.

BD represents 14% market share, leveraging its expertise in medical devices, diagnostic systems, and broad adoption of point-of-care and laboratory-based testing products.

Siemens Healthcare Private Limited holds 11% market share, driven by its high-quality diagnostic analyzers, digital healthcare integration, and strong hospital and laboratory customer base.

OraQuick captures 7% market share, supported by its specialization in rapid infectious disease testing, ease-of-use formats, and strong presence in home-based diagnostics.

SEKISUI Diagnostics accounts for 6% market share, benefiting from its immunoassay reagents, clinical chemistry solutions, and growing footprint in rapid testing markets.

BioLytical Laboratories Inc. (INSTI) represents 5% market share, driven by its rapid HIV diagnostic tests and strong adoption in public health and screening programs.

Nova Biomedical holds 4% market share, supported by its blood gas and critical care diagnostics solutions used in hospital settings.

Everlywell captures 3% market share, leveraging direct-to-consumer diagnostic testing models and expanding at-home health testing services.

Geratherm Medical AG, PRIMA Lab SA, Cardinal Health, and Bionime Corporation together account for 4% market share, focusing on specialty diagnostics, distribution strength, and glucose monitoring solutions.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=at-home-testing-kits-market?sai-v
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Market Drivers
Increasing consumer demand for convenient, quick, and accessible diagnostic solutions driving growth of the at-home testing kits market.

Rising prevalence of chronic diseases, infectious conditions, and preventive healthcare awareness encouraging regular self-screening and monitoring.

Advancements in point-of-care technologies, digital health tools, and immunoassay platforms enabling accurate, user-friendly at-home tests.

Expansion of telemedicine, remote monitoring services, and integration with mobile apps improving test result tracking and patient engagement.

Supportive regulatory frameworks and reimbursement policies in several regions accelerating adoption of at-home diagnostic kits for conditions like COVID-19, pregnancy, glucose monitoring, and STIs.

Industry Developments
Development of novel at-home testing kits covering infectious diseases, hormonal health, fertility, genetic screening, metabolic markers, and micronutrient status.

Integration of digital connectivity and AI-assisted interpretation to enhance test accuracy, result interpretation, and data sharing with healthcare providers.

Strategic partnerships between diagnostic manufacturers, e-health platforms, and pharmacy retailers to expand distribution channels and customer access.

Introduction of multiplex testing platforms enabling simultaneous detection of multiple biomarkers from a single sample.

Advancements in sample collection methods (e.g., saliva, finger-stick blood, urine) and non-invasive technologies enhancing user comfort and compliance.

Regional Insights
North America - 40% share: "Driven by high healthcare awareness, extensive use of digital health tools, strong distribution networks, and early adoption of at-home diagnostic solutions."

Europe - 27% share: "Supported by robust preventive healthcare programs, strong regulatory approval systems, and increasing consumer focus on self-health management."

Asia Pacific - 23% share: "Fueled by rising healthcare access, expanding telemedicine adoption, growing chronic disease burden, and increasing availability of at-home tests."

Latin America - 6% share: "Driven by growing demand for accessible diagnostic options, rising healthcare awareness, and expanding retail pharmacy channels."

Middle East & Africa - 4% share: "Supported by improving healthcare infrastructure, increasing health literacy, and gradual adoption of self-testing solutions."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/at-home-testing-kits-market?sai-v


Key Segments
By Product Type
Digital monitoring instruments account for a significant share, driven by rising adoption of portable, connected, and user-friendly diagnostic devices. Test strips remain widely used due to their low cost, rapid results, and routine application in chronic disease monitoring. Sample collection kits support decentralized and home-based testing, gaining traction with the expansion of self-testing solutions. Other products include cartridges, cassettes, and consumables that enable quick and accurate point-of-care testing.

By Application
Infectious disease testing represents a major segment, supported by the need for rapid diagnosis and early treatment initiation. Glucose monitoring testing holds a substantial share due to the growing prevalence of diabetes and frequent testing requirements. Pregnancy and fertility testing continue to see strong demand in both clinical and home settings. Cholesterol testing is expanding with increased focus on cardiovascular health. Urinalysis testing is widely used for routine screening and disease monitoring, while other applications include cardiac markers and coagulation testing.

By Sample Type
Blood samples dominate point-of-care diagnostics due to their wide applicability across multiple tests. Urine samples are commonly used for pregnancy, fertility, and urinalysis testing. Saliva-based testing is gaining popularity owing to its non-invasive nature and ease of collection. Vaginal swabs are primarily used in reproductive and infectious disease testing. Other sample types include nasal and throat swabs for respiratory diagnostics.

By Distribution Channel
Retail pharmacies account for a significant share, driven by accessibility and increasing availability of over-the-counter test kits. Hospital pharmacies play a critical role in supplying point-of-care diagnostics for inpatient and outpatient settings. Online pharmacies are the fastest-growing channel, supported by e-commerce adoption, home delivery, and consumer preference for privacy and convenience.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.